Polycystic kidney disease complicates renal pathology in a family with Fabry disease

被引:3
作者
Johar, Leepakshi [1 ,2 ]
Lee, Grace [1 ]
Martin-Rios, Angela
Hall, Kathy [1 ]
Cheng, Cheng [1 ]
Lombardo, Dawn [3 ]
Pahl, Madeleine [4 ]
Kimonis, Virginia [1 ,5 ]
机构
[1] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92868 USA
[2] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA
[3] Univ Calif Irvine, Dept Med, Div Nephrol, Irvine, CA 92868 USA
[4] Univ Calif Irvine, Div Nephrol, Irvine, CA 92868 USA
[5] Univ Calif Irvine, Dept Pediat, Div Genet & Genom Med, 101 City Dr South,ZC4482, Orange, CA 92868 USA
关键词
Fabry disease; Polycystic kidney disease; PKD1; CYSTS;
D O I
10.1016/j.ymgmr.2022.100934
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fabry disease is a rare lysosomal storage disorder that primarily affects the heart and kidneys, often presenting with reduced renal function. Polycystic kidney disease is a renal condition in which cysts are found, which have a different presentation than the cysts associated with Fabry disease. We report a 60-year-old male patient who was diagnosed with Fabry disease with the classic c.730G > A (p.Asp244Asn) variant of the GLA gene at 34 years of age. Fabry symptoms in this patient include hypohidrosis, hearing loss, corneal whorling, and edema. He also presented with polycystic kidney disease with multiple simple and mildly complex cysts on abdominal ultra-sound. Family history of note included Fabry disease in his mother and maternal uncle as well as polycystic kidneys in his mother. Molecular analysis for polycystic kidney disease revealed a variant of uncertain signifi-cance (VUS) in the PKD1 gene. Although the in silico studies of this VUS have inconclusive results, the patient fills clinical criteria of autosomal dominant polycystic kidney disease, therefore, Fabry disease and polycystic kidney disease are considered two co-existing manifestations in this family. This case demonstrates the possi-bility of two renal comorbidities in the same individual and the risk of one diagnosis being overlooked by the other.
引用
收藏
页数:4
相关论文
共 16 条
[1]  
Akbar S., 2022, STATPEARLS
[2]   New drugs for the treatment of Anderson-Fabry disease [J].
Feriozzi, Sandro ;
Hughes, Derralynn A. .
JOURNAL OF NEPHROLOGY, 2021, 34 (01) :221-230
[3]  
Genzyme Corporation, 2021, FABR PRESCR INF, P6
[4]   Fabry disease [J].
Germain, Dominique P. .
ORPHANET JOURNAL OF RARE DISEASES, 2010, 5
[5]   Fabry disease: Renal sonographic and magnetic resonance imaging findings in affected males and carrier females with the classic and cardiac variant phenotypes [J].
Glass, RBJ ;
Astrin, KH ;
Norton, KI ;
Parsons, R ;
Eng, CM ;
Banikazemi, M ;
Desnick, RJ .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2004, 28 (02) :158-168
[6]  
Halvorson CR, 2010, INT J NEPHROL RENOV, V3, P69
[7]   Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions [J].
Kok, Ken ;
Zwiers, Kimberley C. ;
Boot, Rolf G. ;
Overkleeft, Hermen S. ;
Aerts, Johannes M. F. G. ;
Artola, Marta .
BIOMOLECULES, 2021, 11 (02) :1-20
[8]   Analysis of protein-coding genetic variation in 60,706 humans [J].
Lek, Monkol ;
Karczewski, Konrad J. ;
Minikel, Eric V. ;
Samocha, Kaitlin E. ;
Banks, Eric ;
Fennell, Timothy ;
O'Donnell-Luria, Anne H. ;
Ware, James S. ;
Hill, Andrew J. ;
Cummings, Beryl B. ;
Tukiainen, Taru ;
Birnbaum, Daniel P. ;
Kosmicki, Jack A. ;
Duncan, Laramie E. ;
Estrada, Karol ;
Zhao, Fengmei ;
Zou, James ;
Pierce-Hollman, Emma ;
Berghout, Joanne ;
Cooper, David N. ;
Deflaux, Nicole ;
DePristo, Mark ;
Do, Ron ;
Flannick, Jason ;
Fromer, Menachem ;
Gauthier, Laura ;
Goldstein, Jackie ;
Gupta, Namrata ;
Howrigan, Daniel ;
Kiezun, Adam ;
Kurki, Mitja I. ;
Moonshine, Ami Levy ;
Natarajan, Pradeep ;
Orozeo, Lorena ;
Peloso, Gina M. ;
Poplin, Ryan ;
Rivas, Manuel A. ;
Ruano-Rubio, Valentin ;
Rose, Samuel A. ;
Ruderfer, Douglas M. ;
Shakir, Khalid ;
Stenson, Peter D. ;
Stevens, Christine ;
Thomas, Brett P. ;
Tiao, Grace ;
Tusie-Luna, Maria T. ;
Weisburd, Ben ;
Won, Hong-Hee ;
Yu, Dongmei ;
Altshuler, David M. .
NATURE, 2016, 536 (7616) :285-+
[9]   RegSNPs-intron: a computational framework for predicting pathogenic impact of intronic single nucleotide variants [J].
Lin, Hai ;
Hargreaves, Katherine A. ;
Li, Rudong ;
Reiter, Jill L. ;
Wang, Yue ;
Mort, Matthew ;
Cooper, David N. ;
Zhou, Yaoqi ;
Zhang, Chi ;
Eadon, Michael T. ;
Dolan, M. Eileen ;
Ipe, Joseph ;
Skaar, Todd C. ;
Liu, Yunlong .
GENOME BIOLOGY, 2019, 20 (01)
[10]   Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany [J].
Neumann, Hartmut P. H. ;
Jilg, Cordula ;
Bacher, Janina ;
Nabulsi, Zinaida ;
Malinoc, Angelica ;
Hummel, Barbara ;
Hoffmann, Michael M. ;
Ortiz-Bruechle, Nadina ;
Glasker, Sven ;
Pisarski, Przemyslaw ;
Neeff, Hannes ;
Kraemer-Guth, Annette ;
Cybulla, Markus ;
Hornberger, Martin ;
Wilpert, Jochen ;
Funk, Ludwig ;
Baumert, Joerg ;
Paatz, Dietrich ;
Baumann, Dieter ;
Lahl, Markus ;
Felten, Helmut ;
Hausberg, Martin ;
Zerres, Klaus ;
Eng, Charis .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (06) :1472-1487